Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.6 USD | -2.32% | -5.98% | -23.85% |
05-20 | Insmed Lung Infections Treatment Study Shows Improvement | MT |
05-15 | Goldman Sachs Adjusts Price Target on Insmed to $49 From $40, Maintains Buy Rating | MT |